How Dietary Nickel Arms Gut Bacteria — and May Fuel Gut Disease

The exposure: where dietary nickel comes from

Nickel enters the body mainly through food and water. Plant foods concentrate it — legumes, nuts, whole grains, cocoa, soy, and oats are among the richest sources — and additional nickel leaches from drinking water, food processing, and stainless-steel cookware. The European Food Safety Authority (EFSA) has set a tolerable daily intake (TDI) of 13 micrograms per kilogram of body weight and identified a lowest-observed-adverse-effect-level (LOAEL) of roughly 4.3 micrograms per day for eczematous reactions in sensitized people. For most adults, ordinary dietary nickel is well tolerated; the question this article asks is not about acute toxicity but about how that steady background of nickel might tune the behavior of gut bacteria.

The exposure question becomes sharpest at the start of life. In a 2025 analysis of 149 infant milk formulae, nickel was detected in 62 samples, and the estimated daily intake from formula exceeded the EFSA LOAEL of 4.3 micrograms in the products tested for infants aged one to six months, with some exceeding the TDI once water used for reconstitution was accounted for (Dobrzyńska et al., 2025). Breast milk is not nickel-free — concentrations vary widely with maternal diet and water — so this is a matter of degree, not a clean formula-versus-breast-milk dichotomy. The relevant point is that formula can deliver a consistent, measurable nickel load during the precise developmental window when the infant gut microbiome is being assembled and is dominated by Enterobacteriaceae.

Nickel as a bacterial weapon, not just a nutrient

What makes nickel biologically interesting in the gut is that bacteria use it to build two enzymes that double as virulence factors. The first is urease, which hydrolyzes urea into ammonia and carbon dioxide — buffering acid, liberating nitrogen for growth, and, at high local concentrations, raising pH and irritating the epithelium. The second is [NiFe]-hydrogenase, which lets bacteria use molecular hydrogen as an energy source and helps them resist oxidative stress. Both enzymes are catalytically dead without a nickel ion inserted into their active sites. A 2019 review by Maier and Benoit frames these as the most notable nickel-associated virulence components across bacterial pathogens, best characterized in the gastric pathogen Helicobacter pylori but shared broadly by gut Enterobacteriaceae such as Escherichia coli, Klebsiella, Proteus, and Salmonella.

Because host tissues keep free nickel scarce, pathogens invest in dedicated import machinery — the NikABCDE ABC-transporter — and, strikingly, repurpose siderophore chemistry to scavenge the metal. Robinson and colleagues (2018) showed that uropathogenic E. coli use the yersiniabactin metallophore, normally thought of as an iron siderophore, to bind extracellular nickel and deliver it to support [NiFe]-hydrogenase activity. That nickel supply is genuinely rate-limiting was demonstrated by Sychantha et al. (2024): blocking the NikA nickel importer with the fungal compound aspergillomarasmine A suppressed urease and hydrogenase activity across pathogens including Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus aureus, and Salmonella Typhimurium — attenuating virulence functions without killing the bacteria. The implication is direct: nickel availability gates these enzymes, so more environmental nickel means more substrate to switch them on.

The microbiome change: which taxa nickel favors

Nickel exposure measurably reshapes the gut community, and it tends to tilt it toward inflammation. In a study of 109 nickel-exposed workers and controls, Yang et al. (2023) found that human exposure was associated with depletion of beneficial taxa — Lactobacillus, Blautia, and Lachnospiraceae — and enrichment of Escherichia-Shigella (a core Enterobacteriaceae group) and Parabacteroides; serum nickel correlated with elevated uric acid (r = 0.413). In the paired mouse arm, nickel raised serum uric acid and systemic inflammation while depleting Lactobacillus and Blautia. A 2025 murine study by Du and colleagues reinforced the inflammatory signature: fifteen days of nickel exposure produced route-dependent dysbiosis, depleting commensals such as Prevotellaceae UCG-001, Rikenellaceae, and Alistipes while enriching opportunists including Enterobacter and Helicobacter, with elevated serum TNF-alpha and predicted enrichment of Th17-cell-differentiation and NOD-like-receptor signaling pathways.

Honesty requires noting that the direction of change is not uniform. A 2026 review by Lusi and Rifici describes how, in nickel-allergic women, rising nickel-sulfate concentrations were associated with a progressive decline in Enterobacteriaceae and an expansion of Lactobacillales, Bacillaceae, and Clostridiaceae — the opposite Enterobacteriaceae trend. The reconciliation is that nickel is an ecological selective pressure whose net effect depends on dose, host genotype, allergy status, and the baseline community: at some exposures it favors nickel-exploiting Enterobacteriaceae, at others it selects for intrinsically nickel-tolerant Gram-positives. What is consistent across studies is dysbiosis and a pro-inflammatory shift, not a single fixed roster of winners and losers.

Disease link 1: necrotizing enterocolitis

Necrotizing enterocolitis (NEC) is a devastating, often fatal intestinal disease of preterm infants. The preterm gut is characteristically unstable, low in diversity, and dominated by Gram-negative Proteobacteria — chiefly Enterobacteriaceae — and NEC is thought to arise when this community triggers an exaggerated TLR4-driven inflammatory response to lipopolysaccharide. Enterobacteriaceae are the most abundant LPS-bearing organisms in that setting, which places them at the mechanistic heart of the disease.

Strain-level evidence sharpens the picture. Ward et al. (2016), using deep metagenomic sequencing of 144 preterm and 22 term infants, implicated uropathogenic E. coli (UPEC) — sequence types including ST69, ST73, ST95, ST127, ST131, and ST144 — in disease. UPEC colonization was associated with NEC (unadjusted odds ratio 4.1, p = 0.003), NEC-associated death (OR 10.3, p < 0.001), and all-cause death (OR 5.7, p < 0.001). These are precisely the lineages shown by Robinson et al. to depend on yersiniabactin-mediated nickel acquisition to power [NiFe]-hydrogenase. The organisms most strongly tied to NEC are, in other words, the gut's nickel-dependent virulence specialists — and formula is a consistent nickel source at exactly the window when they are colonizing. That convergence supports the hypothesis that nickel supply could tune UPEC virulence in the preterm gut. It is a hypothesis, not a demonstrated cause: no trial has yet tested whether lowering formula nickel reduces NEC incidence.

Disease link 2: inflammatory bowel disease

A bloom of Enterobacteriaceae is one of the most reproducible features of the dysbiosis seen in inflammatory bowel disease (IBD). Here the nickel-urease connection is especially suggestive. Bacterial urease is a hub of nitrogen metabolism in the gut: it liberates ammonia from host urea and cross-feeds nitrogen to species that cannot make the enzyme themselves, and urease activity has been linked to dysbiosis and inflammation in murine models of IBD. Klebsiella pneumoniae urease specifically enhances intestinal colonization and competitive fitness (Maroncle et al., 2006), giving urease-positive Enterobacteriaceae a foothold advantage precisely where IBD dysbiosis takes hold.

Layered on top of that colonization advantage is nickel's own pro-inflammatory push. The murine and human data above show nickel driving Th17 differentiation, NOD-like-receptor signaling, and elevated TNF-alpha — the same axes that are dysregulated in IBD. Clinically, Systemic Nickel Allergy Syndrome frequently overlaps with IBS- and IBD-like gastrointestinal symptoms and gut dysbiosis, and a low-nickel diet combined with selected probiotics has been reported to improve both symptoms and the dysbiotic profile. The mechanistic reading is that nickel could act twice over: expanding Enterobacteriaceae and simultaneously arming their urease, amplifying the ammonia-driven epithelial stress and nitrogen cross-feeding characteristic of IBD. As with NEC, the human evidence remains associative rather than causal.

The mechanism, assembled

Put end to end, the proposed pathway reads as follows. Dietary nickel is imported by gut Enterobacteriaceae through NikABCDE transporters and, in uropathogenic strains, the yersiniabactin metallophore. That nickel matures urease and [NiFe]-hydrogenase, which grant the bacteria enhanced colonization, resistance to acid and oxidative stress, access to host nitrogen, and local ammonia production. These advantages promote the competitive expansion of Enterobacteriaceae and UPEC, while urease-derived ammonia and LPS drive TLR4-, NOD-like-receptor-, and Th17-mediated inflammation. In a vulnerable host — the immature, Proteobacteria-dominated preterm gut, or a genetically susceptible IBD patient — that combination tips toward overt disease: NEC in the infant, a flare in IBD.

Each arrow in that chain is individually supported by data. Nickel gates urease and hydrogenase (biochemistry); nickel reshapes the microbiome and raises inflammatory tone (animal and occupational human studies); UPEC and Enterobacteriaceae are tied to NEC and IBD (clinical association). What has not been demonstrated is the entire chain running, start to finish, inside a human being. That is the honest status of the metal-microbiome-disease axis for nickel: a well-motivated, mechanistically coherent hypothesis, not settled causation.

Human versus animal evidence, limitations, and what would confirm it

It helps to grade the evidence by tier. The strongest links are biochemical and mechanistic: nickel is genuinely required for urease and [NiFe]-hydrogenase, and cutting off bacterial nickel supply switches both off (Sychantha 2024; Robinson 2018; Maier and Benoit 2019). The middle tier is animal evidence that nickel causes dysbiosis and inflammation (Yang 2023 mouse arm; Du 2025). The weakest, but not negligible, tier is human association — UPEC with NEC (Ward 2016), Enterobacteriaceae with IBD, and occupational nickel with an Escherichia-Shigella shift and higher uric acid (Yang 2023).

The limitations are real and worth stating plainly. No randomized trial has lowered dietary or formula nickel and measured NEC or IBD outcomes. Nickel's effect on the microbiome is dose- and host-dependent, and the taxa it favors are not identical across studies, which weakens any simple 'nickel feeds Enterobacteriaceae' slogan. Occupational cohorts inhale and ingest far more nickel than a typical diet delivers, and formula differs from breast milk in many ways beyond nickel — iron fortification, human milk oligosaccharides, and immune factors are all confounders that independently shape Enterobacteriaceae. Confirming the hypothesis would require showing that dietary nickel increases fecal urease and hydrogenase activity together with Enterobacteriaceae abundance in vivo; gnotobiotic models in which nickel-replete versus nickel-restricted diets change UPEC virulence and NEC incidence; a formula-nickel-reduction trial with clinical endpoints; and prospective human cohorts linking measured nickel intake to an Enterobacteriaceae bloom and to disease. Until then, nickel belongs in the metal-microbiome-disease framework as a compelling lead — evidence-rich, not yet proven.